Trusted sourcing partnerBest Pharma Supplier
Best PharmaFINISHED DOSAGE PORTFOLIO
Explore Decure’s sourcing portfolio across injectables, tablets, capsules, dry syrups, topical formulations and specialized therapeutic ranges, with multiple strengths, compositions and dosage-form options for institutional and commercial requirements.
BROWSE BY DOSAGE & THERAPY
Sterile injectable formulations for institutional and hospital requirements.
Beta-Lactam and Non-Beta-Lactam formulations across therapeutic categories.
Hard-shell capsule formulations in multiple strengths and compositions.
Paediatric and adult oral liquid and dry-syrup formulation options.
Creams, ointments and other topical dosage-form requirements.
Formulations supporting diabetes-management sourcing requirements.
Cardiovascular formulations across common dosage forms and strengths.
PRODUCT FINDER
Therapeutic Ranges
Diabetic RangeTeneligliptin Hydrobromlde Hydrate 20MG Tablets (film coated) is a tablet formulated with Teneligliptin Hydrobromlde Hydrate 20MG ( ). The listed active ingredient profile is Teneligliptin Hydrobromlde Hydrate, placing the product in the oral antidiabetic
Diabetic RangeTeneligliptin Tablets IP 20mg (Film coated) is a tablet formulated with Teneligliptin IP 20mg ( ). The listed active ingredient profile is Teneligliptin, placing the product in the oral antidiabetic category. The formulation contains one or more oral gluc
Diabetic RangeTenellgliptin 20mg + Metformin Hydrochloride (Extended Release) 500mg Tablets (Uncoated blayered) is a tablet formulated with Tenellgliptin 20mg + Metformin Hydrochloride ( ) 500mg ( blayered). The listed active ingredient profile is Tenellgliptin; Metfor
Cardiac RangeTolvaptan 15mg Tablets (film coated) is a tablet formulated with Tolvaptan 15mg ( ). The listed active ingredient profile is Tolvaptan, placing the product in the vasopressin antagonist / aquaretic category. The active ingredient alters renal free-water h
Cardiac RangeTolvaptan 15Smg Tablet (film coated) is a tablet formulated with Tolvaptan 15Smg ( ). The listed active ingredient profile is Tolvaptan 15Smg, placing the product in the vasopressin antagonist / aquaretic category. The active ingredient alters renal free-
Cardiac RangeTrimetazidine Hydrochloride 20mg Tab. (Film Coated) is a tablet formulated with Trimetazidine Hydrochloride 20mg . ( ). The listed active ingredient profile is Trimetazidine Hydrochloride, placing the product in the antianginal / cardiovascular category.
Cardiac RangeValsartan 160mg + Hydrochlorothiazide 12.5mg Tab. (Filrm coated) is a tablet formulated with Valsartan 160mg + Hydrochlorothiazide 12.5mg . (Filrm coated). The listed active ingredient profile is Valsartan; Hydrochlorothiazide, placing the product in the
Diabetic RangeVildagliptin 50 mg + Metformin HCI 1000 mg Tablets is a tablet formulated with Vildagliptin 50 mg + Metformin HCI 1000 mg. The listed active ingredient profile is Vildagliptin; Metformin HCI, placing the product in the oral antidiabetic category. The form
Diabetic RangeVildagliptin 50mg + Metformin Hydrochlortde 500mg Tablets (Film coated) is a tablet formulated with Vildagliptin 50mg + Metformin Hydrochlortde 500mg ( ). The listed active ingredient profile is Vildagliptin; Metformin Hydrochlortde, placing the product i
Diabetic RangeVildagliptin 50MG Tablet (Uncoated Tablet) is a tablet formulated with Vildagliptin 50MG ( ). The listed active ingredient profile is Vildagliptin, placing the product in the oral antidiabetic category. The formulation contains one or more oral glucose-lo
Diabetic RangeVoglibose 0.2mg + Metformin 500mg Tab. (Uncoated) is a tablet formulated with Voglibose 0.2mg + Metformin 500mg . ( ). The listed active ingredient profile is Voglibose; Metformin, placing the product in the oral antidiabetic category. The formulation con
Diabetic RangeVoglibose 0.2mg Tab. (Uncoated) is a tablet formulated with Voglibose 0.2mg . ( ). The listed active ingredient profile is Voglibose, placing the product in the oral antidiabetic category. The formulation contains one or more oral glucose-lowering medicin
Diabetic RangeVoglibose 0.2mg, Glimepiride Img + Metformin Hydrochloride 500mg Tablets (Uncoated Bilayered) is a bilayered tablet formulated with Voglibose 0.2mg, Glimepiride Img + Metformin Hydrochloride 500mg ( ). The listed active ingredient profile is Voglibose; Gl
Diabetic RangeVoglibose 0.2mg. Glimepiide 2mg + Metformin Hydrochloide 500mg Tablets (Uncoated Bilayered) is a bilayered tablet formulated with Voglibose 0.2mg. Glimepiide 2mg + Metformin Hydrochloide 500mg ( ). The listed active ingredient profile is Voglibose . Glime
Diabetic RangeVoglibose lP 0.3 mg + Glimepride IP1 mg + Metformin Hcl IP SR 500 mg (Uncoated Tab) is a tablet formulated with Voglibose lP 0.3 mg + Glimepride IP1 mg + Metformin Hcl IP SR 500 mg ( ). The listed active ingredient profile is Voglibose lP; Glimepride IP1
Diabetic RangeVoglibose O.3mg + Metformin 500mg Tab. (Uncoated) is a tablet formulated with Voglibose O.3mg + Metformin 500mg . ( ). The listed active ingredient profile is Voglibose O; Metformin, placing the product in the oral antidiabetic category. The formulation c
FROM BRIEF TO SUPPLY
Share dosage form, strength, quantity and destination.
We review availability and documentation expectations.
Commercial and supply requirements move forward together.
HUMAN FORMULATIONS
